Your browser is no longer supported. Please, upgrade your browser.
HAE [NYSE]
Haemonetics Corporation
Index- P/E55.24 EPS (ttm)1.26 Insider Own0.90% Shs Outstand50.94M Perf Week-1.04%
Market Cap3.55B Forward P/E23.14 EPS next Y3.00 Insider Trans-9.45% Shs Float50.70M Perf Month15.82%
Income64.50M PEG5.52 EPS next Q0.61 Inst Own92.06% Short Float4.11% Perf Quarter5.34%
Sales903.40M P/S3.93 EPS this Y4.90% Inst Trans2.77% Short Ratio3.28 Perf Half Y-40.17%
Book/sh13.29 P/B5.23 EPS next Y8.65% ROA4.10% Target Price79.25 Perf Year-19.79%
Cash/sh3.39 P/C20.48 EPS next 5Y10.00% ROE9.20% 52W Range49.26 - 142.11 Perf YTD-41.48%
Dividend- P/FCF68.33 EPS past 5Y27.90% ROI6.70% 52W High-50.95% Beta0.35
Dividend %- Quick Ratio1.60 Sales past 5Y-0.90% Gross Margin46.30% 52W Low41.50% ATR1.88
Employees2708 Current Ratio3.00 Sales Q/Q16.80% Oper. Margin8.80% RSI (14)63.67 Volatility2.95% 2.77%
OptionableYes Debt/Eq1.16 EPS Q/Q-142.60% Profit Margin7.10% Rel Volume0.14 Prev Close69.49
ShortableYes LT Debt/Eq1.13 EarningsAug 11 BMO Payout0.00% Avg Volume634.67K Price69.71
Recom1.70 SMA204.73% SMA5011.66% SMA200-21.05% Volume8,045 Change0.31%
Aug-17-21Resumed Raymond James Outperform $75
Jun-17-21Initiated Citigroup Buy $75
May-14-21Upgrade CJS Securities Market Perform → Market Outperform
Apr-20-21Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-19-21Downgrade CJS Securities Market Outperform → Market Perform
Feb-03-21Upgrade Barrington Research Mkt Perform → Outperform $140
Jan-21-21Downgrade Barrington Research Outperform → Mkt Perform
Nov-05-20Upgrade Barrington Research Mkt Perform → Outperform $106
May-06-20Downgrade Barrington Research Outperform → Mkt Perform
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Jan-10-20Initiated Needham Buy $138
Aug-07-19Reiterated Barrington Research Outperform $116 → $139
May-14-19Upgrade Raymond James Mkt Perform → Outperform $110
May-08-19Reiterated Barrington Research Outperform $112 → $116
Aug-09-18Reiterated Barrington Research Outperform $90 → $118
Feb-07-18Reiterated Barrington Research Outperform $57 → $71
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-08-17Reiterated Barrington Research Outperform $48 → $57
Aug-08-17Upgrade Barrington Research Mkt Perform → Outperform $48
Jul-13-17Upgrade JMP Securities Mkt Perform → Mkt Outperform
Sep-10-21 11:30AM  
Sep-05-21 10:10AM  
Sep-01-21 11:33AM  
Aug-25-21 08:52AM  
Aug-12-21 09:44AM  
09:02AM  
Aug-11-21 11:00AM  
07:15AM  
06:00AM  
Aug-10-21 04:30PM  
Aug-09-21 06:45AM  
Aug-04-21 03:00PM  
Jul-31-21 03:33AM  
Jul-09-21 04:51PM  
Jul-01-21 09:32AM  
Jun-29-21 08:43AM  
Jun-20-21 05:28AM  
02:54AM  
May-17-21 07:24AM  
May-14-21 05:56PM  
03:29AM  
May-13-21 06:01PM  
02:00PM  
12:11PM  
06:00AM  
05:45AM  
May-12-21 10:51AM  
06:22AM  
May-06-21 03:00PM  
May-03-21 10:39AM  
Apr-29-21 06:45AM  
Apr-26-21 11:56AM  
10:14AM  
Apr-23-21 04:05PM  
Apr-19-21 07:47AM  
06:00AM  
Apr-06-21 05:19AM  
Mar-24-21 09:59AM  
Mar-07-21 03:09AM  
Mar-04-21 11:30AM  
Mar-02-21 08:21PM  
Mar-01-21 04:05PM  
Feb-26-21 06:50AM  
Feb-04-21 11:59PM  
Feb-03-21 08:16AM  
Feb-02-21 04:30PM  
07:30AM  
07:09AM  
06:00AM  
05:45AM  
Feb-01-21 10:55AM  
Jan-26-21 12:31PM  
12:12PM  
Jan-22-21 09:50AM  
06:45AM  
Jan-20-21 06:45AM  
Jan-18-21 10:05AM  
Jan-05-21 05:03PM  
Dec-21-20 04:13PM  
Dec-04-20 11:31AM  
Dec-01-20 10:52AM  
Nov-06-20 02:28PM  
Nov-05-20 10:34AM  
08:44AM  
Nov-04-20 07:30AM  
07:11AM  
06:15AM  
06:00AM  
Oct-28-20 12:32PM  
Oct-06-20 04:15PM  
Oct-02-20 08:36PM  
Sep-09-20 04:53PM  
Sep-08-20 08:08PM  
Sep-03-20 11:31AM  
Aug-07-20 06:45AM  
Aug-05-20 09:52AM  
07:37AM  
Aug-04-20 07:30AM  
07:28AM  
06:00AM  
Jul-28-20 12:32PM  
Jul-24-20 06:45AM  
Jul-22-20 05:57PM  
Jul-09-20 08:53PM  
Jul-06-20 04:15PM  
Jun-30-20 04:15PM  
Jun-08-20 10:08AM  
Jun-05-20 09:47AM  
Jun-03-20 06:45AM  
01:10AM  
May-28-20 04:18PM  
May-26-20 12:39AM  
May-11-20 08:03AM  
May-06-20 11:33AM  
May-05-20 09:01PM  
May-04-20 04:41PM  
01:36PM  
11:02AM  
09:08AM  
Apr-28-20 12:33PM  
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx and El-Dorado Donor donation and blood unit management systems; Hemasphere software that provides support for blood drive planning; and Donor Doc and e-Donor software to enhance the donor recruitment and retention. In addition, the company offers hospital products comprising TEG diagnostic systems that enables clinicians to assess the coagulation status of a patient at the point-of-care or laboratory setting; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and BloodTrack, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Llorens JosepEVP, Global ManufacturingSep 07Sale64.611006,46114,520Sep 09 04:56 PM
Burke William P. Mr.EVP, Chief Financial OfficerAug 23Option Exercise37.9622,667860,40052,958Aug 25 04:15 PM
Burke William P. Mr.EVP, Chief Financial OfficerAug 23Sale60.5122,6671,371,58030,291Aug 25 04:15 PM
Burke William P. Mr.EVP, Chief Financial OfficerJul 01Sale66.604,293285,91430,291Jul 06 04:21 PM
Goldstein DanVP, Corporate ControllerJun 14Sale59.87392,3354,054Jun 16 04:39 PM
Basil Michelle LEVP and General CounselJun 14Sale59.8719511,67538,410Jun 16 04:35 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 14Sale59.8719011,37534,584Jun 16 04:31 PM
Simon, ChristopherPresident & CEOJun 14Sale59.871,20071,844191,806Jun 16 04:29 PM
Goldstein DanVP, Corporate ControllerJun 07Sale55.09814,4624,093Jun 09 04:35 PM
Scanlan JacquelineSVP, Global Human ResourcesJun 07Sale55.0919510,7434,216Jun 09 04:33 PM
Basil Michelle LEVP and General CounselJun 07Sale55.0944224,35038,605Jun 09 04:31 PM
Burke William P. Mr.EVP, Chief Financial OfficerJun 07Sale55.0941122,64234,774Jun 09 04:29 PM
Simon, ChristopherPresident & CEOJun 07Sale55.092,715149,569193,006Jun 09 04:27 PM
KROLL MARK WDirectorMay 26Option Exercise35.5010,353367,55730,253May 28 04:09 PM
KROLL MARK WDirectorMay 26Sale55.1011,813650,89618,440May 28 04:09 PM
Goldstein DanVP, Corporate ControllerMay 19Sale55.19422,3182,421May 20 06:08 PM
Lingamneni AnilaEVP, Chief Technology OfficerMay 19Sale55.19925,07714,202May 20 06:07 PM
Llorens JosepSVP, Global ManufacturingMay 19Sale55.191256,89914,620May 20 06:05 PM
Basil Michelle LEVP and General CounselMay 19Sale55.1922012,14239,047May 20 06:02 PM
Burke William P. Mr.EVP, Chief Financial OfficerMay 19Sale55.1923813,13535,185May 20 05:58 PM
Simon, ChristopherPresident & CEOMay 19Sale55.191,02456,515195,721May 20 05:55 PM
Scanlan JacquelineSVP, Global Human ResourcesMay 19Sale55.191126,1814,411May 21 06:26 AM
Llorens JosepSVP, Global ManufacturingMay 17Sale55.971146,3814,140May 18 06:30 PM
Goldstein DanVP, Corporate ControllerMay 17Sale55.97422,3511,469May 18 06:31 PM
Scanlan JacquelineSVP, Global Human ResourcesMay 17Sale55.971025,7094,523May 18 06:27 PM
Basil Michelle LEVP and General CounselMay 17Sale55.9720411,41815,403May 18 06:25 PM
Burke William P. Mr.EVP, Chief Financial OfficerMay 17Sale55.9721912,25711,118May 18 06:16 PM
Simon, ChristopherPresident & CEOMay 17Sale55.9795653,507170,230May 18 06:14 PM
Lingamneni AnilaEVP, Chief Technology OfficerApr 16Sale119.4417020,3053,444Apr 20 04:20 PM
Scanlan JacquelineSVP, Global Human ResourcesMar 08Sale120.0710712,8474,380Mar 10 04:11 PM
Basil Michelle LEVP and General CounselMar 08Sale120.0738546,22715,607Mar 10 04:08 PM
Goldstein DanVP, Corporate ControllerFeb 04Option Exercise58.932,433143,3723,206Feb 05 04:36 PM
Dockendorff Charles JDirectorFeb 04Option Exercise35.5012,180432,42025,935Feb 05 04:46 PM
MEELIA RICHARD JDirectorFeb 04Option Exercise35.5010,353367,55742,403Feb 05 04:51 PM
Dockendorff Charles JDirectorFeb 04Sale134.5312,1801,638,57513,755Feb 05 04:46 PM
Goldstein DanVP, Corporate ControllerFeb 04Sale135.862,671362,8881,511Feb 05 04:36 PM
MEELIA RICHARD JDirectorFeb 04Sale134.6410,3531,393,92832,050Feb 05 04:51 PM
Goldstein DanVP, Corporate ControllerOct 26Sale106.0010010,6001,749Oct 28 05:02 PM
Burke William P. Mr.EVP, Chief Financial OfficerOct 26Sale106.001,161123,06611,337Oct 28 04:59 PM
Basil Michelle LEVP and General CounselOct 23Sale106.5818119,29115,992Oct 26 04:55 PM